Method and compounds for aica riboside delivery and for lowering blood glucose
US5658889A · kind A · utility
53Cited by
3References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 1994 |
| Grant date | Aug 19, 1997 |
| Priority date | — |
| Expiry date | Dec 14, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/052
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
AICA riboside and prodrugs of AICA riboside are provided which lower blood glucose for the treatment of various pathologic conditions, including hypoglycemia, insulin deficiency, insulin resistance diabetes and Syndrome X. Prodrugs of AICA riboside provide AICA riboside in an orally bioavailable form. The use of adenosine kinase inhibition and ZMP enhancement for lowering blood glucose are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.